Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 572

1.

Biomarkers in primary prevention : Meaningful diagnosis based on biomarker scores?

Schulte C, Zeller T.

Herz. 2019 Dec 5. doi: 10.1007/s00059-019-04874-2. [Epub ahead of print]

PMID:
31807790
2.

Gender-Specific Reference Values for High-Sensitivity Cardiac Troponin T and I in Well-Phenotyped Healthy Individuals and Validity of High-Sensitivity Assay Designation.

Giannitsis E, Mueller-Hennessen M, Zeller T, Schuebler A, Aurich M, Bieneram M, Vafaie M, Stoyanov K, Ochs M, Riffel J, Mereles D, Blankenberg S, Katus HA.

Clin Biochem. 2019 Nov 28. pii: S0009-9120(19)30918-X. doi: 10.1016/j.clinbiochem.2019.11.013. [Epub ahead of print]

3.

Time trends of vitamin D concentrations in northern Sweden between 1986 and 2014: a population-based cross-sectional study.

Summerhays E, Eliasson M, Lundqvist R, Söderberg S, Zeller T, Oskarsson V.

Eur J Nutr. 2019 Nov 21. doi: 10.1007/s00394-019-02142-x. [Epub ahead of print]

PMID:
31754783
4.

Temporal relations between atrial fibrillation and ischaemic stroke and their prognostic impact on mortality.

Camen S, Ojeda FM, Niiranen T, Gianfagna F, Vishram-Nielsen JK, Costanzo S, Söderberg S, Vartiainen E, Donati MB, Løchen ML, Pasterkamp G, Magnussen C, Kee F, Jousilahti P, Hughes M, Kontto J, Mathiesen EB, Koenig W, Palosaari T, Blankenberg S, de Gaetano G, Jørgensen T, Zeller T, Kuulasmaa K, Linneberg A, Salomaa V, Iacoviello L, Schnabel RB.

Europace. 2019 Nov 18. pii: euz312. doi: 10.1093/europace/euz312. [Epub ahead of print]

PMID:
31740944
5.

Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target population.

Blaum C, Brunner FJ, Kröger F, Braetz J, Lorenz T, Goßling A, Ojeda F, Koester L, Karakas M, Zeller T, Westermann D, Schnabel R, Blankenberg S, Seiffert M, Waldeyer C.

Eur J Prev Cardiol. 2019 Nov 10:2047487319885458. doi: 10.1177/2047487319885458. [Epub ahead of print]

PMID:
31707846
6.

Rationale and Design of the Hamburg City Health Study.

Jagodzinski A, Johansen C, Koch-Gromus U, Aarabi G, Adam G, Anders S, Augustin M, der Kellen RB, Beikler T, Behrendt CA, Betz CS, Bokemeyer C, Borof K, Briken P, Busch CJ, Büchel C, Brassen S, Debus ES, Eggers L, Fiehler J, Gallinat J, Gellißen S, Gerloff C, Girdauskas E, Gosau M, Graefen M, Härter M, Harth V, Heidemann C, Heydecke G, Huber TB, Hussein Y, Kampf MO, von dem Knesebeck O, Konnopka A, König HH, Kromer R, Kubisch C, Kühn S, Loges S, Löwe B, Lund G, Meyer C, Nagel L, Nienhaus A, Pantel K, Petersen E, Püschel K, Reichenspurner H, Sauter G, Scherer M, Scherschel K, Schiffner U, Schnabel RB, Schulz H, Smeets R, Sokalskis V, Spitzer MS, Terschüren C, Thederan I, Thoma T, Thomalla G, Waschki B, Wegscheider K, Wenzel JP, Wiese S, Zyriax BC, Zeller T, Blankenberg S.

Eur J Epidemiol. 2019 Nov 8. doi: 10.1007/s10654-019-00577-4. [Epub ahead of print]

PMID:
31705407
7.

Diagnostic Evaluation of a High-Sensitivity Troponin I Point-of-Care Assay.

Sörensen NA, Neumann JT, Ojeda F, Giannitsis E, Spanuth E, Blankenberg S, Westermann D, Zeller T.

Clin Chem. 2019 Dec;65(12):1592-1601. doi: 10.1373/clinchem.2019.307405. Epub 2019 Nov 7.

PMID:
31699700
8.

Efficacy and Safety of a Novel Paclitaxel-Nano-Coated Balloon for Femoro-Popliteal Angioplasty: 1-Year Results of EffPac Trial.

Teichgräber U, Lehmann T, Aschenbach R, Scheinert D, Zeller T, Brechtel K, Blessing E, Lichtenberg M, Sixt S, Brucks S, Beschorner U, Klumb CT, Thieme M; Collaborators.

EuroIntervention. 2019 Nov 5. pii: EIJ-D-19-00292. doi: 10.4244/EIJ-D-19-00292. [Epub ahead of print]

9.

Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium.

Cavus E, Karakas M, Ojeda FM, Kontto J, Veronesi G, Ferrario MM, Linneberg A, Jørgensen T, Meisinger C, Thorand B, Iacoviello L, Börnigen D, Woodward M, Schnabel R, Costanzo S, Tunstall-Pedoe H, Koenig W, Kuulasmaa K, Salomaa V, Blankenberg S, Zeller T; BiomarCaRE consortium.

JAMA Cardiol. 2019 Oct 30:1-10. doi: 10.1001/jamacardio.2019.4130. [Epub ahead of print]

PMID:
31664431
10.

First-in-Human Experience With Sirolimus-Eluting Self-Expanding Stent for Femoropopliteal Lesions.

Steiner S, Sauguet A, Langhoff R, Kahlberg A, Thieme M, Zeller T, Garot P, Commeau P, Cremonesi A, Marone EM, Scheinert D.

J Am Coll Cardiol. 2019 Oct 29;74(17):2216-2218. doi: 10.1016/j.jacc.2019.08.1019. No abstract available.

PMID:
31648715
11.

Mortality Assessment of Paclitaxel-Coated Balloons: Patient-Level Meta-Analysis of the ILLUMENATE Clinical Program at 3 Years.

Gray WA, Jaff MR, Parikh SA, Ansel GM, Brodmann M, Krishnan P, Razavi MK, Vermassen F, Zeller T, White R, Ouriel K, Adelman MA, Lyden SP.

Circulation. 2019 Oct;140(14):1145-1155. doi: 10.1161/CIRCULATIONAHA.119.040518. Epub 2019 Sep 30.

12.

The SAPPHIRE criteria, history of myocardial infarction and diabetes predict adverse outcomes following carotid endarterectomy similar to stenting.

Macharzina RR, Müller C, Vogt M, Messé SR, Vach W, Winker T, Weinbeck M, Siepe M, Czerny M, Neumann FJ, Zeller T.

Clin Res Cardiol. 2019 Sep 25. doi: 10.1007/s00392-019-01546-3. [Epub ahead of print]

PMID:
31555985
13.

Total IN.PACT drug-coated balloon initiative reporting pooled imaging and propensity-matched cohorts.

Shishehbor MH, Schneider PA, Zeller T, Razavi MK, Laird JR, Wang H, Tieché C, Parikh SA, Iida O, Jaff MR.

J Vasc Surg. 2019 Oct;70(4):1177-1191.e9. doi: 10.1016/j.jvs.2019.02.030.

14.

Prognostic Value of a Novel and Established High-Sensitivity Troponin I Assay in Patients Presenting with Suspected Myocardial Infarction.

Sörensen NA, Ludwig S, Makarova N, Neumann JT, Lehmacher J, Hartikainen TS, Haller PM, Keller T, Blankenberg S, Westermann D, Zeller T, Schofer N.

Biomolecules. 2019 Sep 9;9(9). pii: E469. doi: 10.3390/biom9090469.

15.

Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated Devices.

Dake MD, Ansel GM, Bosiers M, Holden A, Iida O, Jaff MR, Lottes AE, O'Leary EE, Saunders AT, Schermerhorn M, Yokoi H, Zeller T.

Cardiovasc Intervent Radiol. 2019 Sep 9. doi: 10.1007/s00270-019-02324-4. [Epub ahead of print]

PMID:
31502026
16.

Propensity Score-Adjusted Comparison of Long-Term Outcomes Among Revascularization Strategies for Critical Limb Ischemia.

Mustapha JA, Katzen BT, Neville RF, Lookstein RA, Zeller T, Miller LE, Nelson TR, Jaff MR.

Circ Cardiovasc Interv. 2019 Sep;12(9):e008097. doi: 10.1161/CIRCINTERVENTIONS.119.008097. Epub 2019 Sep 9.

PMID:
31495219
17.

Functional Characterization of Rare Variants in the SHOX2 Gene Identified in Sinus Node Dysfunction and Atrial Fibrillation.

Hoffmann S, Paone C, Sumer SA, Diebold S, Weiss B, Roeth R, Clauss S, Klier I, Kääb S, Schulz A, Wild PS, Ghrib A, Zeller T, Schnabel RB, Just S, Rappold GA.

Front Genet. 2019 Jul 11;10:648. doi: 10.3389/fgene.2019.00648. eCollection 2019.

18.

Cardiovascular Biomarkers in Amniotic Fluid, Umbilical Arterial Blood, Umbilical Venous Blood, and Maternal Blood at Delivery, and Their Reference Values for Full-Term, Singleton, Cesarean Deliveries.

Blohm ME, Arndt F, Fröschle GM, Langenbach N, Sandig J, Vettorazzi E, Mir TS, Hecher K, Weil J, Kozlik-Feldmann R, Blankenberg S, Zeller T, Singer D.

Front Pediatr. 2019 Jul 2;7:271. doi: 10.3389/fped.2019.00271. eCollection 2019.

19.

Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.

Neumann JT, Twerenbold R, Ojeda F, Sörensen NA, Chapman AR, Shah ASV, Anand A, Boeddinghaus J, Nestelberger T, Badertscher P, Mokhtari A, Pickering JW, Troughton RW, Greenslade J, Parsonage W, Mueller-Hennessen M, Gori T, Jernberg T, Morris N, Liebetrau C, Hamm C, Katus HA, Münzel T, Landmesser U, Salomaa V, Iacoviello L, Ferrario MM, Giampaoli S, Kee F, Thorand B, Peters A, Borchini R, Jørgensen T, Söderberg S, Sans S, Tunstall-Pedoe H, Kuulasmaa K, Renné T, Lackner KJ, Worster A, Body R, Ekelund U, Kavsak PA, Keller T, Lindahl B, Wild P, Giannitsis E, Than M, Cullen LA, Mills NL, Mueller C, Zeller T, Westermann D, Blankenberg S.

N Engl J Med. 2019 Jun 27;380(26):2529-2540. doi: 10.1056/NEJMoa1803377.

PMID:
31242362
20.

Pro-Angiogenic Macrophage Phenotype to Promote Myocardial Repair.

Ferraro B, Leoni G, Hinkel R, Ormanns S, Paulin N, Ortega-Gomez A, Viola JR, de Jong R, Bongiovanni D, Bozoglu T, Maas SL, D'Amico M, Kessler T, Zeller T, Hristov M, Reutelingsperger C, Sager HB, Döring Y, Nahrendorf M, Kupatt C, Soehnlein O.

J Am Coll Cardiol. 2019 Jun 18;73(23):2990-3002. doi: 10.1016/j.jacc.2019.03.503.

21.

Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions.

Laird JA, Schneider PA, Jaff MR, Brodmann M, Zeller T, Metzger DC, Krishnan P, Scheinert D, Micari A, Wang H, Masters M, Tepe G.

Circ Cardiovasc Interv. 2019 Jun;12(6):e007702. doi: 10.1161/CIRCINTERVENTIONS.118.007702. Epub 2019 Jun 14.

22.

Paclitaxel and Mortality: The Dose Argument Is Critical.

Holden A, Varcoe RL, Jaff MR, Schneider PA, Tepe G, Zeller T.

J Endovasc Ther. 2019 Aug;26(4):467-470. doi: 10.1177/1526602819857241. Epub 2019 Jun 9. No abstract available.

PMID:
31179816
23.

Comparative Analysis of Circulating Noncoding RNAs Versus Protein Biomarkers in the Detection of Myocardial Injury.

Schulte C, Barwari T, Joshi A, Theofilatos K, Zampetaki A, Barallobre-Barreiro J, Singh B, Sörensen NA, Neumann JT, Zeller T, Westermann D, Blankenberg S, Marber M, Liebetrau C, Mayr M.

Circ Res. 2019 Jul 19;125(3):328-340. doi: 10.1161/CIRCRESAHA.119.314937. Epub 2019 Jun 4.

24.

Identification of acute myocardial infarction in elderly patients using optimized highly sensitive troponin I thresholds.

von Jeinsen B, Liebetrau C, Palapies L, Tzikas S, Zeller T, Bickel C, Schmidt A, Tubaro M, Lackner KJ, Sar F, Baldus S, Zeiher AM, Blankenberg S, Gori T, Münzel T, Hamm CW, Wild PS, Keller T.

Biomarkers. 2019 Sep;24(6):549-555. doi: 10.1080/1354750X.2019.1606276. Epub 2019 Jun 13.

PMID:
31159594
25.

Improved Carotid Stenosis Quantification on Novel 4D/3D-Doppler Ultrasonography Indexing to the Common Carotid Artery.

Macharzina RR, Kocher S, Messe SR, Kammerer T, Hoffmann F, Vogt M, Vach W, Fan N, Rastan A, Neumann FJ, Zeller T.

Ultraschall Med. 2019 May 29. doi: 10.1055/a-0628-6459. [Epub ahead of print]

PMID:
31141825
26.

Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: A translational review of current literature.

Reichart D, Magnussen C, Zeller T, Blankenberg S.

J Intern Med. 2019 Oct;286(4):362-372. doi: 10.1111/joim.12944. Epub 2019 Jul 29. Review.

PMID:
31132311
27.

Predictive value of low testosterone concentrations regarding coronary heart disease and mortality in men and women - evidence from the FINRISK97 study.

Zeller T, Appelbaum S, Kuulasmaa K, Palosaari T, Blankenberg S, Jousilahti P, Salomaa V, Karakas M.

J Intern Med. 2019 Sep;286(3):317-325. doi: 10.1111/joim.12943. Epub 2019 Jun 14.

28.

Cardiac glial cells release neurotrophic S100B upon catheter-based treatment of atrial fibrillation.

Scherschel K, Hedenus K, Jungen C, Lemoine MD, Rübsamen N, Veldkamp MW, Klatt N, Lindner D, Westermann D, Casini S, Kuklik P, Eickholt C, Klöcker N, Shivkumar K, Christ T, Zeller T, Willems S, Meyer C.

Sci Transl Med. 2019 May 22;11(493). pii: eaav7770. doi: 10.1126/scitranslmed.aav7770.

PMID:
31118294
29.

Relative Telomere Length and Cardiovascular Risk Factors.

Koriath M, Müller C, Pfeiffer N, Nickels S, Beutel M, Schmidtmann I, Rapp S, Münzel T, Westermann D, Karakas M, Wild PS, Lackner KJ, Blankenberg S, Zeller T.

Biomolecules. 2019 May 17;9(5). pii: E192. doi: 10.3390/biom9050192.

30.

Acute Outcomes With a Novel Plaque Modification System in Real-World Femoropopliteal Lesions.

Zeller T, Lopez L, Pigott JP.

J Endovasc Ther. 2019 Jun;26(3):333-341. doi: 10.1177/1526602819849955.

PMID:
31106694
31.

[Anti-Thrombotic Therapy of Peripheral Arterial Disease - A Review of Current Evidence, Practice and Outlook].

Bauersachs R, Espinola-Klein C, Lawall H, Storck M, Zeller T, Debus S.

Dtsch Med Wochenschr. 2019 May;144(10):683-689. doi: 10.1055/a-0826-2868. Epub 2019 May 13. Review. German.

PMID:
31083738
32.

Safety and efficacy of endovascular ultrasound renal denervation in resistant hypertension: 12-month results from the ACHIEVE study.

Daemen J, Mahfoud F, Kuck KH, Andersson B, Böhm M, Graf T, Sievert H, Kahlert P, Iyer M, Zeller T.

J Hypertens. 2019 Sep;37(9):1906-1912. doi: 10.1097/HJH.0000000000002120.

PMID:
31045964
33.

iCAST Balloon-Expandable Covered Stent for Iliac Artery Lesions: 3-Year Results from the iCARUS Multicenter Study.

Laird JR, Loja M, Zeller T, Niazi KAK, Foster MT, Ansel G, Stone DH, Dave RM, Popma JJ, Jaff MR, Massaro JM.

J Vasc Interv Radiol. 2019 Jun;30(6):822-829.e4. doi: 10.1016/j.jvir.2018.12.707. Epub 2019 Apr 25.

34.

Predictive value of soluble urokinase-type plasminogen activator receptor for mortality in patients with suspected myocardial infarction.

Sörensen NA, Nikorowitsch J, Neumann JT, Rübsamen N, Goßling A, Hartikainen TS, Blankenberg S, Westermann D, Zeller T, Karakas M.

Clin Res Cardiol. 2019 Dec;108(12):1386-1393. doi: 10.1007/s00392-019-01475-1. Epub 2019 Apr 16.

35.

Prevalence of Clinic First Curricula: A Survey of AFMRD Members.

Zeller TA, Ewing JA, Asif IM.

Fam Med. 2019 Apr;51(4):338-343. doi: 10.22454/FamMed.2019.666943.

36.

Balloon-Expandable Vascular Covered Stent in the Treatment of Iliac Artery Occlusive Disease: 9-Month Results from the BOLSTER Multicenter Study.

Laird JR, Zeller T, Holden A, Scheinert D, Moore E, Mendes R, Schmiedel R, Settlage R, Lansky A, Jaff MR; BOLSTER Investigators.

J Vasc Interv Radiol. 2019 Jun;30(6):836-844.e1. doi: 10.1016/j.jvir.2018.12.031. Epub 2019 Apr 5.

37.

Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.

Reijnen MMPJ, van Wijck I, Zeller T, Micari A, Veroux P, Keirse K, Lee SW, Li P, Voulgaraki D, Holewijn S.

J Endovasc Ther. 2019 Jun;26(3):305-315. doi: 10.1177/1526602819839044. Epub 2019 Apr 1.

38.

Long noncoding RNA NEAT1 modulates immune cell functions and is suppressed in early onset myocardial infarction patients.

Gast M, Rauch BH, Haghikia A, Nakagawa S, Haas J, Stroux A, Schmidt D, Schumann P, Weiss S, Jensen L, Kratzer A, Kraenkel N, Müller C, Börnigen D, Hirose T, Blankenberg S, Escher F, Kühl AA, Kuss AW, Meder B, Landmesser U, Zeller T, Poller W.

Cardiovasc Res. 2019 Nov 1;115(13):1886-1906. doi: 10.1093/cvr/cvz085.

PMID:
30924864
39.

Diagnostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Addition to High-Sensitivity Troponin I in Early Diagnosis of Acute Myocardial Infarction.

Sörensen NA, Dönmez G, Neumann JT, Nikorowitsch J, Rübsamen N, Blankenberg S, Westermann D, Zeller T, Karakas M.

Biomolecules. 2019 Mar 18;9(3). pii: E108. doi: 10.3390/biom9030108.

40.

Angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy compared to best medical treatment: One-year interim results of SPACE-2.

Reiff T, Eckstein HH, Mansmann U, Jansen O, Fraedrich G, Mudra H, Böckler D, Böhm M, Brückmann H, Debus ES, Fiehler J, Lang W, Mathias K, Ringelstein EB, Schmidli J, Stingele R, Zahn R, Zeller T, Hetzel A, Bodechtel U, Binder A, Glahn J, Hacke W, Ringleb PA.

Int J Stroke. 2019 Mar 15:1747493019833017. doi: 10.1177/1747493019833017. [Epub ahead of print]

41.

Correction to: Impact of Patient and Lesion Characteristics on Drug-Coated Balloon Angioplasty in the Femoropopliteal Artery: A Pooled Analysis of Four Randomized Controlled Multicenter Trials.

Albrecht T, Ukrow A, Werk M, Tepe G, Zeller T, Meyer DR, Kutschera M, Speck U, Waliszewski M.

Cardiovasc Intervent Radiol. 2019 Jul;42(7):1055. doi: 10.1007/s00270-019-02203-y.

PMID:
30863966
42.

Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The Chronic Total Occlusion Cohort in the IN.PACT Global Study.

Tepe G, Micari A, Keirse K, Zeller T, Scheinert D, Li P, Schmahl R, Jaff MR; IN.PACT Global Study Investigators.

JACC Cardiovasc Interv. 2019 Mar 11;12(5):484-493. doi: 10.1016/j.jcin.2018.12.004.

43.

Outstanding effectiveness of paclitaxel-based technologies for the treatment of femoropopliteal artery occlusive disease on the potential expense of increased late all-cause mortality? No reason to panic.

Zeller T, Noory E, Beschorner U, Böhme T, Mpj Reijnen M.

Vasa. 2019 Mar;48(2):109-111. doi: 10.1024/0301-1526/a000778. No abstract available.

PMID:
30821214
44.

Left ventricular geometry and function in early repolarization: results from the population-based Gutenberg Health Study.

Trenkwalder T, Rübsamen N, Schmitt VH, Arnold N, Kaess BM, Sinning CR, Zeller T, Beutel ME, Schmidtmann I, Nickels S, Pfeiffer N, Leuschner A, Münzel T, Lackner KJ, Hengstenberg C, Blankenberg S, Wild PS, Reinhard W, Schnabel R.

Clin Res Cardiol. 2019 Oct;108(10):1107-1116. doi: 10.1007/s00392-019-01445-7. Epub 2019 Feb 28.

PMID:
30820639
45.

Sex-Specific Epidemiology of Heart Failure Risk and Mortality in Europe: Results From the BiomarCaRE Consortium.

Magnussen C, Niiranen TJ, Ojeda FM, Gianfagna F, Blankenberg S, Vartiainen E, Sans S, Pasterkamp G, Hughes M, Costanzo S, Donati MB, Jousilahti P, Linneberg A, Palosaari T, de Gaetano G, Bobak M, den Ruijter HM, Jørgensen T, Söderberg S, Kuulasmaa K, Zeller T, Iacoviello L, Salomaa V, Schnabel RB; BiomarCaRE Consortium.

JACC Heart Fail. 2019 Mar;7(3):204-213. doi: 10.1016/j.jchf.2018.08.008.

PMID:
30819375
46.

NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and the Risk of Stroke.

Di Castelnuovo A, Veronesi G, Costanzo S, Zeller T, Schnabel RB, de Curtis A, Salomaa V, Borchini R, Ferrario M, Giampaoli S, Kee F, Söderberg S, Niiranen T, Kuulasmaa K, de Gaetano G, Donati MB, Blankenberg S, Iacoviello L; BiomarCaRE Investigators.

Stroke. 2019 Mar;50(3):610-617. doi: 10.1161/STROKEAHA.118.023218.

PMID:
30786848
47.

Double Filtration During Carotid Artery Stenting Using a Novel Post-Dilation Balloon With Integrated Embolic Protection.

Langhoff R, Schofer J, Scheinert D, Schmidt A, Sedgewick G, Saylors E, Sachar R, Sievert H, Zeller T.

JACC Cardiovasc Interv. 2019 Feb 25;12(4):395-403. doi: 10.1016/j.jcin.2018.11.039.

PMID:
30784647
48.

Common Genetic Variation in Relation to Brachial Vascular Dimensions and Flow-Mediated Vasodilation.

Dörr M, Hamburg NM, Müller C, Smith NL, Gustafsson S, Lehtimäki T, Teumer A, Zeller T, Li X, Lind L, Raitakari OT, Völker U, Blankenberg S, McKnight B, Morris AP, Kähönen M, Lemaitre RN, Wild PS, Nauck M, Völzke H, Münzel T, Mitchell GF, Psaty BM, Lindgren CM, Larson MG, Felix SB, Ingelsson E, Lyytikäinen LP, Herrington D, Benjamin EJ, Schnabel RB.

Circ Genom Precis Med. 2019 Feb;12(2):e002409. doi: 10.1161/CIRCGEN.118.002409. No abstract available.

PMID:
30779634
49.

Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease.

Bausback Y, Wittig T, Schmidt A, Zeller T, Bosiers M, Peeters P, Brucks S, Lottes AE, Scheinert D, Steiner S.

J Am Coll Cardiol. 2019 Feb 19;73(6):667-679. doi: 10.1016/j.jacc.2018.11.039.

50.

Use of Paclitaxel-Eluting Technologies in the Femoropopliteal Segment Under Scrutiny Over Possible Link to Late All-Cause Mortality: Time to Panic or an Opportunity to Resurge?

Fanelli F, Cortese B, Zeller T.

J Endovasc Ther. 2019 Feb;26(1):41-43. doi: 10.1177/1526602818824682. No abstract available.

PMID:
30760131

Supplemental Content

Loading ...
Support Center